NVCR
NovoCure Ltd. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website novocure.com
- Employees(FY) 1320
- ISIN JE00BYSS4X48
Performance
+16.07%
1W
+10.69%
1M
+7.58%
3M
+43.47%
6M
+10.31%
YTD
-76.96%
1Y
Profile
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. The company was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Investment Analysis Report: NVCR
Overview
In this investment analysis report, we will delve into the financial statements of NovoCure Limited (NVCR), a company in the Health Technology sector specializing in Medical Specialties. We will analyze the Balance Sheets, Income Statements, and Cashflow Statements to gain insights into the company's fin...
Technical Analysis of NVCR 2024-05-03
Overview:
In analyzing the technical indicators for NVCR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been showing an upward trend,...
Recent News & Updates
- 2024-05-03 12:08
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-05-03 01:00
NovoCure (NVCR) Q1 2024 Earnings Call Transcript(Motley Fool)
- 2024-05-02 13:19
- 2024-05-02 08:45
- 2024-05-02 08:25
- 2024-05-02 07:28
NovoCure: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-02 07:01
- 2024-05-02 07:00
Novocure Reports First Quarter 2024 Financial Results(Business Wire)
- 2024-05-01 23:56
- 2024-05-01 20:25
- 2024-05-01 19:01
- 2024-05-01 19:00
Novocure Reports First Quarter 2024 Financial Results(Businesswire)
- 2024-04-25 10:01
- 2024-04-24 22:01
- 2024-04-24 10:45
- 2024-04-23 22:45
- 2024-04-05 07:00
- 2024-04-04 19:00
- 2024-04-03 23:33
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts(Insidermonkey)
- 2024-04-01 12:00
- 2024-04-01 07:00
Novocure to Report First Quarter 2024 Financial Results(Business Wire)
- 2024-04-01 00:00
- 2024-03-31 19:00
Novocure to Report First Quarter 2024 Financial Results(Businesswire)
- 2024-03-30 06:34
Why NovoCure Stock Soared 18.3% This Week(Motley Fool)
- 2024-03-28 11:50
Why Novocure Stock Is Jumping Today(Motley Fool)
- 2024-03-28 05:01
- 2024-03-27 17:01
- 2024-03-27 16:08
Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish(Investor's Business Daily)
- 2024-03-27 09:16
Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment(Investor's Business Daily)
- 2024-03-27 07:14
Page 1 of 6
previousnext